
T3S Technologies Inc Profile last edited on: 9/15/2017
CAGE: 7FY13
UEI: P4URP7XL1H53
Business Identifier: NO Business Identifier is currently available for this company. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 01
County: Salt Lake
Congr. District: 01
County: Salt Lake
Public Profile
T3S Technologies provides genetically engineered bacterial cells designed to expand their biologics manufacturing capabilities and dramatically shortens the current manufacturing process. The firm has developed a bacterial expression system aimed at reducing the cost of producing biologics such as insulin, fabs, filgrastim, ScFv, and Interferon ß-1b.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2016 | 1 | NSF | $225,000 | |
Project Title: Novel Continuous Flow Manufacturing of Recombinant Proteins Secreted Through the Bacterial Type-III Secretion System |
Key People / Management
Fabienne Chevance -- Founder
Daniel Wee -- Founder
Daniel Wee -- Founder
Company News
There are no news available.